Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Rapid oral HIV test shows great promise according to MUHC-led research

Rapid oral HIV test shows great promise according to MUHC-led research

April 12, 2007

A convenient, easy to use, and rapid alternative to blood-based HIV testing may become the new standard for field testing according to a new MUHC study. The study shows that the oral fluid-based OraQuick HIV1/2 test is 100 per cent accurate and patients' preferred choice.

Senior and lead author Dr. Nitika Pai, a postdoctoral fellow at the McGill University Health Centre (MUHC), and her colleagues tested 450 individuals for HIV infection at the Mahatma Gandhi Institute of Medical Sciences in Sevagram India. Thirty two percent were found to be HIV positive. Researchers compared the diagnostic accuracy of the OraQuick test from two samples-one obtained from oral fluid (saliva) and the other from a blood-based finger stick-with traditional blood tests. They demonstrated that the oral fluid test had 100 per cent accuracy versus the finger-stick blood test, which showed one false positive (99.7 per cent specificity). There was little reported discomfort during sample collection for the oral test, but 66 per cent of the individuals reported discomfort with the finger testing.




Although the oral OraQuick test has been approved by the US Food and Drug Administration, some previous studies had indicated that it was not sufficiently precise. As a result, the Centre for Disease Control (CDC) called for more definitive studies leading to this study in rural India.

"Based on our findings, the oral test is the preferred choice for HIV field testing by rural Indians," says Dr. Pai, a physician epidemiologist supported by the Canadian HIV Trials Network. "The other advantages are that results are available within 40 minutes compared to the standard blood test, which takes up to two weeks. This test can also be performed by health workers with minimal training, eliminating the need for specialist laboratory technicians."

"Rapid point of care HIV testing is a very important component of HIV control initiatives and programs. In particular, non-invasive, simple, accurate oral fluid-based, rapid tests have the potential to make a big impact on HIV screening. They open the door to the possibility of home-based HIV testing," she says.

McGill University



Related Oraquick Current Events and Oraquick News Articles
FDA ignores critical information on home HIV tests
The FDA is ignoring critical information in deciding whether to approve an over-the-counter, rapid HIV test for home use.
More Oraquick Current Events and Oraquick News Articles
OraSure OraQuick ADVANCE Rapid HIV-1/2 Antibody Test, Box of 100

OraSure OraQuick ADVANCE Rapid HIV-1/2 Antibody Test, Box of 100
by OraSure Technologies

OraQuick ADVANCEĀ® Rapid HIV-1/2 Antibody Test is: Rapid Provides results in 20 minutes, enabling patients to learn their status in a single visit and allows HIV positive patients to be connected to care immediately. Flexible Approved for oral fluid, plasma, fingerstick or venipuncture whole blood specimens. Ideal for both clinical and non-clinical settings. Accurate Greater than 99% agreement with confirmatory Western blot. Simple CLIA-waived for oral fluid, fingerstick and venipuncture whole blood and offers the ability to test in non-traditional testing environments, such as outreach programs and mobile testing clinics. Patient-Preferred Offers patients accurate HIV testing without the need for blood or needles. Pain-free testing with oral fluid means more people get...

  OraQuick rapid HIV-1 antibody test. (New & Approved).: An article from: Internal Medicine News
by Elizabeth Mechcatie (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on December 15, 2002. The length of the article is 434 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: OraQuick rapid HIV-1 antibody test. (New & Approved).
Author: Elizabeth Mechcatie
Publication: Internal Medicine News (Magazine/Journal)
Date: December 15, 2002
Publisher: International Medical News Group
Volume: 35 Issue: 24 Page: 33(1)

Distributed by Thomson...

Home Access HIV - 1 Test System - 1 ea

Home Access HIV - 1 Test System - 1 ea
by Home Access

Please note: Due to packaging updates, the image shown may temporarily appear different

  Zetia * OraQuick rapid HIV-1 antibody test. (New & Approved).(Brief Article): An article from: Family Practice News
by Elizabeth Mechcatie (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on December 15, 2002. The length of the article is 751 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Zetia * OraQuick rapid HIV-1 antibody test. (New & Approved).(Brief Article)
Author: Elizabeth Mechcatie
Publication: Family Practice News (Magazine/Journal)
Date: December 15, 2002
Publisher: International Medical News Group
Volume: 32 Issue: 24 Page: 26(1)

Article Type: Brief Article

Distributed by Thomson...

Home Access HIV - 1 Express Test System - 1 ea

Home Access HIV - 1 Express Test System - 1 ea
by Home Access

Next Day Results*
Contains one single-use sample collection kit

  U.S. FDA APPROVES ORAQUICK ADVANCER 12-MONTH SHELF LIFE DATING.: An article from: Biotech Business
by Gale Reference Team (Author)

This digital document is an article from Biotech Business, published by Worldwide Videotex on March 1, 2009. The length of the article is 345 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: U.S. FDA APPROVES ORAQUICK ADVANCER 12-MONTH SHELF LIFE DATING.
Author: Gale Reference Team
Publication: Biotech Business (Newsletter)
Date: March 1, 2009
Publisher: Worldwide Videotex
Volume: 22 Issue: 3 Page: NA

Distributed by Gale, a part of Cengage...

  ORASURE SUBMITS ORAQUICK HCV TEST PMA TO FDA.: An article from: Biotech Business
by Gale Reference Team (Author)

This digital document is an article from Biotech Business, published by Worldwide Videotex on December 1, 2008. The length of the article is 764 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: ORASURE SUBMITS ORAQUICK HCV TEST PMA TO FDA.
Author: Gale Reference Team
Publication: Biotech Business (Newsletter)
Date: December 1, 2008
Publisher: Worldwide Videotex
Volume: 21 Issue: 12 Page: NA

Distributed by Gale, a part of Cengage...

© 2009 BrightSurf.com